DiaMedica Therapeutics (DMAC) EBT (2018 - 2026)
DiaMedica Therapeutics (DMAC) reported EBT of -$10.0 million for Q1 2026, down 30.31% on a YoY basis from -$14.4 million in Q1 2025, and down 10.14% quarter-over-quarter from -$9.1 million in Q4 2025.
DiaMedica Therapeutics (DMAC) EBT (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics has reported EBT for 9 years, with the latest figure at -$10.0 million in Q1 2026.
- For the quarter ending Q1 2026, EBT fell 30.31% year-over-year to -$10.0 million; the trailing twelve-month figure through Mar 2026 stood at -$35.5 million (down 31.26% YoY), and the FY2025 full-year result was -$33.1 million, down 35.44% from the prior year.
- EBT for Q1 2026 stood at -$10.0 million, down from -$9.1 million in the prior quarter.
- The five-year high for EBT was -$3.1 million in Q3 2022, with the low at -$10.0 million in Q1 2026.
- Historically, EBT has averaged -$5.9 million across 5 years, with a median of -$5.1 million in 2024.
- Annual changes were most pronounced in 2022 — EBT increased 11.36% — and 2024, when it tumbled 54.29%.
- DiaMedica Therapeutics' EBT stood at -$3.7 million in 2022, then sank by 37.26% to -$5.1 million in 2023, then plunged by 54.29% to -$7.9 million in 2024, then retreated by 14.91% to -$9.1 million in 2025, then fell by 10.14% to -$10.0 million in 2026.
- The last three EBT figures came in at -$10.0 million (Q1 2026), -$9.1 million (Q4 2025), and -$8.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -15.31 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -3.18 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -56.48 Mn |
| 10 | DiaMedica Therapeutics | 285.11 Mn | 233.77 Mn | - | -10.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.04 Mn |
| Dec 31, 2025 | -9.11 Mn |
| Sep 30, 2025 | -8.61 Mn |
| Jun 30, 2025 | -7.69 Mn |
| Mar 31, 2025 | -7.70 Mn |
| Dec 31, 2024 | -7.93 Mn |
| Sep 30, 2024 | -6.27 Mn |
| Jun 30, 2024 | -5.11 Mn |
| Mar 31, 2024 | -5.14 Mn |
| Dec 31, 2023 | -5.14 Mn |
| Sep 30, 2023 | -4.46 Mn |
| Jun 30, 2023 | -4.47 Mn |
| Mar 31, 2023 | -5.27 Mn |
| Dec 31, 2022 | -3.74 Mn |
| Sep 30, 2022 | -3.05 Mn |
| Jun 30, 2022 | -3.35 Mn |
| Mar 31, 2022 | -3.50 Mn |
| Dec 31, 2021 | -3.24 Mn |
| Sep 30, 2021 | -3.44 Mn |
| Jun 30, 2021 | -3.27 Mn |